FSMAX
Price
$94.93
Change
-$0.10 (-0.11%)
Updated
Aug 5 closing price
Net Assets
39.63B
NMPAX
Price
$14.28
Change
-$0.01 (-0.07%)
Updated
Aug 5 closing price
Net Assets
2.5B
Interact to see
Advertisement

FSMAX vs NMPAX

Header iconFSMAX vs NMPAX Comparison
Open Charts FSMAX vs NMPAXBanner chart's image
Fidelity Extended Market Index
Price$94.93
Change-$0.10 (-0.11%)
VolumeN/A
Net Assets39.63B
Columbia Mid Cap Index Inst
Price$14.28
Change-$0.01 (-0.07%)
VolumeN/A
Net Assets2.5B
FSMAX vs NMPAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSMAX vs. NMPAX commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Hold and NMPAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 39.6B vs. NMPAX (2.5B). NMPAX pays higher dividends than FSMAX: NMPAX (1.31) vs FSMAX (0.46). FSMAX was incepted earlier than NMPAX: FSMAX (14 years) vs NMPAX (25 years). NMPAX (0.33) is less costly to investors than FSMAX (0.04). NMPAX is a more actively managed with annual turnover of: 16.00 vs. FSMAX (9.00). FSMAX has a lower initial minimum investment than NMPAX: FSMAX (0) vs NMPAX (2000). FSMAX annual gain was more profitable for investors over the last year : 21.86 vs. NMPAX (1.49). FSMAX return over 5 years is better than : 52.00 vs. NMPAX (6.00).
FSMAXNMPAXFSMAX / NMPAX
Total Expense Ratio0.040.2018%
Annual Report Gross Expense Ratio0.040.3311%
Fund Existence14 years25 years-
Gain YTD4.566-1.290-354%
Front LoadN/AN/A-
Min. Initial Investment02000-
Min. Initial Investment IRAN/AN/A-
Net Assets39.6B2.5B1,582%
Annual Yield % from dividends0.461.3135%
Returns for 1 year21.861.491,470%
Returns for 3 years38.843.831,015%
Returns for 5 years52.006.00867%
Returns for 10 years84.21-1.13-7,474%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LE13.130.46
+3.63%
Lands' End
HALO60.810.82
+1.37%
Halozyme Therapeutics
CHSCP28.590.07
+0.23%
CHS
ICCC6.18-0.06
-0.96%
ImmuCell Corp
SRPT16.75-0.35
-2.05%
Sarepta Therapeutics